Clinical Outcomes Using Stereotactic MRI-Guided Adaptive Radiation Therapy (SMART) for Primary and Metastatic Abdominal and Pelvic Tumors
P. Lee(University of California, Los Angeles), Michael L. Steinberg(University of California, Los Angeles), Ming‐xin Cao(Sichuan University), Argin G. Mikaeilian(University of California, Los Angeles), Daniel J. Low(University of California, Los Angeles), Mitsuyoshi Hagio(University of California, Los Angeles), Amar U. Kishan(University of California, Los Angeles), Ann C. Raldow(University of California, Los Angeles), Anusha Kalbasi(Stanford Medicine), James Lamb(University of California, Los Angeles), P.J. Beron(University of California, Los Angeles), Elaine Luterstein(University of California San Diego)
International Journal of Radiation Oncology*Biology*Physics
October 19, 2018
Cited by 0
Related Papers
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma
|Cancer Cell|2020|379
Adaptive Radiation Therapy (ART) Strategies and Technical Considerations: A State of the ART Review From NRG Oncology
|International Journal of Radiation Oncology*Biology*Physics|2020|314
Metastasis and Immune Evasion from Extracellular cGAMP Hydrolysis
|Cancer Discovery|2020|293
A Multi-Institutional Experience of MR-Guided Liver Stereotactic Body Radiation Therapy
|Advances in Radiation Oncology|2018|161
Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma
|Science Translational Medicine|2020|129